LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 19

Search options

  1. Article: Fatty Acid Supplementation During

    Aardema, H / Bertijn, I / van Tol, Hta / Rijneveld, A / Vernooij, Jcm / Gadella, B M / Vos, Plam

    Frontiers in cell and developmental biology

    2022  Volume 10, Page(s) 837405

    Abstract: ... In ... ...

    Abstract In vitro
    Language English
    Publishing date 2022-03-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2737824-X
    ISSN 2296-634X
    ISSN 2296-634X
    DOI 10.3389/fcell.2022.837405
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: 149 Uptake of C18:0 from culture media during invitro culture decreases cryosurvival rates of bovine embryos

    Bertijn, I / Gadella, B. M / van Tol, H. T. A / Rijneveld, A / Vos, P. L. A. M / Aardema, H

    Reproduction, fertility, and development. 2021, v. 33, no. 2

    2021  

    Abstract: Cryosurvival of invitro-produced bovine embryos is lower than that of invivo-produced embryos, limiting their usability in the field. Previous work showed that the embryo’s lipid composition relates to its quality and cryosurvival. The present study ... ...

    Abstract Cryosurvival of invitro-produced bovine embryos is lower than that of invivo-produced embryos, limiting their usability in the field. Previous work showed that the embryo’s lipid composition relates to its quality and cryosurvival. The present study aimed to investigate the effects of free fatty acid (FA) additions to embryo culture media during the oviduct phase of embryonic development on the improvement of cryosurvival of invitro-produced blastocysts. Bovine cumulus–oocyte complexes (n=1675, 3 replicates) were harvested from slaughterhouse ovaries, invitro matured (23h), and subsequently fertilized (18–20h). Embryos were cultured until Day 5 post-fertilization in synthetic oviductal fluid (SOF) with (1) bovine serum albumin (BSA; control, n=253); (2) delipidified BSA (>96% FA free, n=460); (3), delipidified BSA complexed with 25µM unsaturated oleic acid (C18:1, n=455); or (4) with saturated stearic acid (C18:0, n=507) with a stoichiometry of 5:1. At Day 5, SOF was refreshed and embryos were cultured without supplementation. At Days 7 and 8, blastocyst rates were determined. Blastocysts were LD540 stained for lipid droplets (LD), and the LD number and size were analysed by ANOVA. Cryosurvival%, defined by re-expansion of the blastocoel, was analysed by logistic regression. Additionally, fresh and frozen–thawed blastocysts were stained for apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labelling, TUNEL), necrosis (EthD-1), and DNA (Hoechst 33342) and analysed using negative binomial regression. Group differences were tested using a post hoc Tukey test. Statistical analysis was performed in R Studio (version 3.4.2), and P-values <0.05 were considered significant. FA-free culture delayed and decreased blastocyst rates to 19% compared with any FA supplementation: 35%, 27%, and 29% for control, C18:1, and C18:0, respectively (P<0.04). Cryosurvival doubled with culture in FA-free SOF (58%) and C18:1 (63%) compared with C18:0 (23% P=0.01 and P<0.01, respectively) and control (29%; P=0.15 and P<0.02, respectively), approaching cryosurvival rates of donated multiple ovulation embryo transfer (MOET) embryos (CRV Company; 67%). C18:0 exposure also resulted in elevated necrosis levels after cryopreservation (5–8% of cells), compared with all groups (2–4%; P<0.016). The LD size increased in blastocysts cultured with C18:1 compared with all groups (3.1µm2 vs. 2.4–2.7µm2; P<0.016). C18:0 addition to SOF during embryo culture invitro, as well as a mixture of FA in control SOF (including C18:0), caused a reduction of ∼50% in blastocyst cryosurvival compared with MOET blastocysts. Interestingly, either C18:1 addition or the complete omission of FA in SOF during embryo culture invitro restored the cryosurvival of blastocysts to the level of MOET blastocysts. Currently, we are investigating whether the free FA conditions in the oviduct endorse the distinct quality between invivo- and invitro-produced embryos.
    Keywords DNA ; apoptosis ; blastocyst ; bovine serum albumin ; cattle ; cryopreservation ; embryo culture ; embryo transfer ; embryogenesis ; free fatty acids ; freeze-thaw cycles ; lipid composition ; necrosis ; nucleotidyltransferases ; oleic acid ; oviducts ; ovulation ; regression analysis ; slaughterhouses ; stearic acid ; stoichiometry
    Language English
    Size p. 183.
    Publishing place CSIRO Publishing
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 1019913-5
    ISSN 1448-5990 ; 1031-3613
    ISSN (online) 1448-5990
    ISSN 1031-3613
    DOI 10.1071/RDv33n2Ab149
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial.

    van Vuren, Annelies / Kerkhoffs, Jean Louis / Schols, Saskia / Rijneveld, Anita / Nur, Erfan / Peereboom, Dore / Gandon, Yves / Welsing, Paco / van Wijk, Richard / Schutgens, Roger / van Solinge, Wouter / Marx, Joannes / Leiner, Tim / Biemond, Bart / van Beers, Eduard

    American journal of hematology

    2022  Volume 97, Issue 7, Page(s) 924–932

    Abstract: Iron overload is a severe general complication of hereditary anemias. Treatment with iron chelators is hampered by important side-effects, high costs, and the lack of availability in many countries with a high prevalence of hereditary anemias. In this ... ...

    Abstract Iron overload is a severe general complication of hereditary anemias. Treatment with iron chelators is hampered by important side-effects, high costs, and the lack of availability in many countries with a high prevalence of hereditary anemias. In this phase III randomized placebo-controlled trial, we assigned adults with non-transfusion-dependent hereditary anemias with mild-to-moderate iron overload to receive esomeprazole (at a dose of 40 mg twice daily) or placebo for 12 months in a cross-over design. The primary end point was change of liver iron content measured by MRI. A total of 30 participants were enrolled in the trial. Treatment with esomeprazole resulted in a statistically significant reduction in liver iron content that was 0.55 mg Fe/g dw larger than after treatment with placebo (95%CI [0.05 to 1.06]; p = 0.03). Median baseline liver iron content at the start of esomeprazole was 4.99 versus 4.49 mg Fe/g dw at start of placebo. Mean delta liver iron content after esomeprazole treatment was -0.57 (SD 1.20) versus -0.11 mg Fe/g dw (SD 0.75) after placebo treatment. Esomeprazole was well tolerated, reported adverse events were mild and none of the patients withdrew from the study due to side effects. In summary, esomeprazole resulted in a significant reduction in liver iron content when compared to placebo in a heterogeneous group of patients with non-transfusion-dependent hereditary anemias. From an international perspective this result can have major implications given the fact that proton pump inhibitors may frequently be the only realistic therapy for many patients without access to or not tolerating iron chelators.
    MeSH term(s) Adult ; Anemia/chemically induced ; Cross-Over Studies ; Double-Blind Method ; Esomeprazole/adverse effects ; Esomeprazole/therapeutic use ; Hemochromatosis/complications ; Humans ; Iron/therapeutic use ; Iron Chelating Agents/adverse effects ; Iron Overload/etiology ; Proton Pumps/therapeutic use ; Treatment Outcome
    Chemical Substances Iron Chelating Agents ; Proton Pumps ; Iron (E1UOL152H7) ; Esomeprazole (N3PA6559FT)
    Language English
    Publishing date 2022-05-10
    Publishing country United States
    Document type Clinical Trial, Phase III ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 196767-8
    ISSN 1096-8652 ; 0361-8609
    ISSN (online) 1096-8652
    ISSN 0361-8609
    DOI 10.1002/ajh.26581
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.

    Jabbour, Elias / Zugmaier, Gerhard / Agrawal, Vaibhav / Martínez-Sánchez, Pilar / Rifón Roca, José J / Cassaday, Ryan D / Böll, Boris / Rijneveld, Anita / Abdul-Hay, Maher / Huguet, Françoise / Cluzeau, Thomas / Díaz, Mar Tormo / Vucinic, Vladan / González-Campos, José / Rambaldi, Alessandro / Schwartz, Stefan / Berthon, Céline / Hernández-Rivas, Jesús María / Gordon, Paul R /
    Brüggemann, Monika / Hamidi, Ali / Chen, Yuqi / Wong, Hansen L / Panwar, Bharat / Katlinskaya, Yuliya / Markovic, Ana / Kantarjian, Hagop

    American journal of hematology

    2024  Volume 99, Issue 4, Page(s) 586–595

    Abstract: Blinatumomab is a BiTE® (bispecific T-cell engager) molecule that redirects ... ...

    Abstract Blinatumomab is a BiTE® (bispecific T-cell engager) molecule that redirects CD3
    MeSH term(s) Adult ; Humans ; Remission Induction ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Antibodies, Bispecific/adverse effects ; Lymphoma, B-Cell/drug therapy ; Pathologic Complete Response ; Acute Disease ; Neoplasm, Residual ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Antineoplastic Agents/adverse effects
    Chemical Substances blinatumomab (4FR53SIF3A) ; Antibodies, Bispecific ; Antineoplastic Agents
    Language English
    Publishing date 2024-02-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 196767-8
    ISSN 1096-8652 ; 0361-8609
    ISSN (online) 1096-8652
    ISSN 0361-8609
    DOI 10.1002/ajh.27227
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Improving chemotherapy processes with a protocol-based information system: a pre and post-implementation study.

    Pirnejad, Habibollah / Gao, Chen / Reddingius, Roel / Rijneveld, Anita / Bal, Roland

    International journal of medical informatics

    2013  Volume 82, Issue 4, Page(s) 220–229

    Abstract: Background: The medical application domain has been a great challenge for information technology solutions for decades, especially when the target process has been complex and multidisciplinary such as chemotherapy processes.: Objective: To evaluate ... ...

    Abstract Background: The medical application domain has been a great challenge for information technology solutions for decades, especially when the target process has been complex and multidisciplinary such as chemotherapy processes.
    Objective: To evaluate the impact of a homegrown protocol based information system on the efficiency of chemotherapy workflow processes in an outpatient setting.
    Methods: A day care unit of the Hematology/Oncology outpatient clinic of Erasmus Medical Center was the setting for this study. The study consisted of comparison of pre- and post-implementation of four workflow efficiency related external indicators: turn-around times of a commonly administered chemotherapy course (Paclitaxel-Carboplatin), chemotherapy course administration postponing rate, the rate of recording course administration time, and patient admission rate of the outpatient clinic. The data was gathered retrospectively from patient charts and information systems' log files. For the purpose of turn-around-time 109 Paclitaxel-Carboplatin chemotherapy courses of pre-implementation were compared to 118 those of post-implementation. For the other indicators: 247 chemotherapy courses pre-implementation were compared to 324 courses post-implementation. The process maps of pre- and post-implementation were also compared to each other.
    Results: The implementation of the system improved the process by removing repetition and sequencing of the tasks. Following the implementation, chemotherapy postponing decreased by 17.2% (Z = -4.723, P = .000) and there were 5.7% less records with missing administration time (Z =-3.047, P = .002). The admission rate increased 1.9 patient per working day (t(94) = -5.974, P = .000). The overall turn-around-time reduced 18.9 min following the implementation (t(169) = 3.48, P = .001). In a multivariate multiple regression model the reduction in turn-around time was related to the implementation of the system (Pillai's Trace = 0.159, F(4,161) = 7.613, P = .000).
    Conclusion: Information systems based on treatment protocols can reduce communication and synchronization needs between the stakeholders in a complex workflow process. These systems can help reengineering the process and improve workflow efficiency by removing unnecessary sequencing and repetitions of tasks.
    MeSH term(s) Antineoplastic Agents/therapeutic use ; Clinical Protocols ; Humans ; Information Systems ; Neoplasms/drug therapy ; Patient Admission ; Quality of Health Care
    Chemical Substances Antineoplastic Agents
    Language English
    Publishing date 2013-04
    Publishing country Ireland
    Document type Comparative Study ; Journal Article
    ZDB-ID 1466296-6
    ISSN 1872-8243 ; 1386-5056
    ISSN (online) 1872-8243
    ISSN 1386-5056
    DOI 10.1016/j.ijmedinf.2012.12.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Zwangerschap en sikkelcelziekte: een combinatie met potentieel ernstige complicaties.

    Lagro, M G P / Rijneveld, A W / Duvekot, J J

    Nederlands tijdschrift voor geneeskunde

    2008  Volume 152, Issue 32, Page(s) 1753–1756

    Abstract: Three women with sickle cell disease were hospitalised during pregnancy. The first patient, 26 years old, was admitted with a sickle cell crisis at a gestational age of 23 weeks; she subsequently developed preeclampsia with foetal growth retardation. A ... ...

    Title translation Pregnancy and sickle cell disease: a combination with potentially serious complications.
    Abstract Three women with sickle cell disease were hospitalised during pregnancy. The first patient, 26 years old, was admitted with a sickle cell crisis at a gestational age of 23 weeks; she subsequently developed preeclampsia with foetal growth retardation. A stillborn foetus was delivered at 24 weeks after termination of pregnancy. Histopathology of the placenta showed multiple infarctions possibly due to sickle cell disease. The second patient, 22 years old, was treated for sickle cell crisis and preterm labour. She delivered healthy twins at 29 weeks by Caesarean section. Postoperatively, an acute chest syndrome was treated with antibiotics and erythrocytapheresis. The third patient, 25 years old, was treated post partum for multiple venous thromboembolic events. Management of sickle cell-related complications is the same in pregnant and nonpregnant women. We recommend counselling women with sickle cell disease prior to conception and testing partners for haemoglobinopathy. The pregnant sickle cell patient needs specialised care from a multidisciplinary team including obstetricians, haematologists, neonatologists and anaesthesiologists.
    MeSH term(s) Adult ; Anemia, Sickle Cell/blood ; Anemia, Sickle Cell/complications ; Anemia, Sickle Cell/prevention & control ; Cesarean Section ; Female ; Fetal Death/etiology ; Fetal Growth Retardation/etiology ; Fetal Growth Retardation/prevention & control ; Gestational Age ; Humans ; Infant, Newborn ; Obstetric Labor, Premature/etiology ; Obstetric Labor, Premature/prevention & control ; Pre-Eclampsia/etiology ; Pre-Eclampsia/prevention & control ; Pregnancy ; Pregnancy Complications, Hematologic/diagnosis ; Pregnancy Complications, Hematologic/prevention & control ; Pregnancy Outcome ; Pregnancy, High-Risk ; Risk Factors ; Treatment Outcome
    Language Dutch
    Publishing date 2008-08-09
    Publishing country Netherlands
    Document type Case Reports ; English Abstract ; Journal Article
    ZDB-ID 82073-8
    ISSN 1876-8784 ; 0028-2162
    ISSN (online) 1876-8784
    ISSN 0028-2162
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Sickle cell disease: Clinical presentation and management of a global health challenge.

    Houwing, M E / de Pagter, P J / van Beers, E J / Biemond, B J / Rettenbacher, E / Rijneveld, A W / Schols, E M / Philipsen, J N J / Tamminga, R Y J / van Draat, K Fijn / Nur, E / Cnossen, M H

    Blood reviews

    2019  Volume 37, Page(s) 100580

    Abstract: Sickle cell disease is an autosomal recessive, multisystem disorder, characterised by chronic haemolytic anaemia, painful episodes of vaso-occlusion, progressive organ failure and a reduced life expectancy. Sickle cell disease is the most common ... ...

    Abstract Sickle cell disease is an autosomal recessive, multisystem disorder, characterised by chronic haemolytic anaemia, painful episodes of vaso-occlusion, progressive organ failure and a reduced life expectancy. Sickle cell disease is the most common monogenetic disease, with millions affected worldwide. In well-resourced countries, comprehensive care programs have increased life expectancy of sickle cell disease patients, with almost all infants surviving into adulthood. Therapeutic options for sickle cell disease patients are however, still scarce. Predictors of sickle cell disease severity and a better understanding of pathophysiology and (epi)genetic modifiers are warranted and could lead to more precise management and treatment. This review provides an extensive summary of the pathophysiology and management of sickle cell disease and encompasses the characteristics, complications and current and future treatment options of the disease.
    MeSH term(s) Anemia, Sickle Cell/complications ; Global Health ; Humans
    Language English
    Publishing date 2019-05-20
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 639015-8
    ISSN 1532-1681 ; 0268-960X
    ISSN (online) 1532-1681
    ISSN 0268-960X
    DOI 10.1016/j.blre.2019.05.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival.

    Dinmohamed, A G / Szabó, A / van der Mark, M / Visser, O / Sonneveld, P / Cornelissen, J J / Jongen-Lavrencic, M / Rijneveld, A W

    Leukemia

    2016  Volume 30, Issue 2, Page(s) 310–317

    Abstract: This nationwide population-based study assessed trends in treatment, trial participation and survival among 1833 adult patients diagnosed with acute lymphoblastic leukemia (ALL) in the Netherlands between 1989 and 2012 reported to the Netherlands Cancer ... ...

    Abstract This nationwide population-based study assessed trends in treatment, trial participation and survival among 1833 adult patients diagnosed with acute lymphoblastic leukemia (ALL) in the Netherlands between 1989 and 2012 reported to the Netherlands Cancer Registry. Patients were categorized into four periods and five age groups (18-24, 25-39, 40-59, 60-69 and ⩾70 years). The application of allogeneic stem cell transplantation (alloSCT), particularly reduced-intensity conditioning (RIC) alloSCT, increased over time up to age 70 years. The inclusion rate in the trials was 67, 66, 55, 58 and 0% for the five age groups. Survival improved over time for patients below 70 years. Five-year relative survival in the period 2007-2012 was 75, 57, 37, 22 and 5% for the five age groups. In that same period, 5-year overall survival among patients aged 18-39 years was 68% for the chemotherapy-alone group and 66% for the alloSCT group. For patients aged 40-69 years, the corresponding estimates were 24 and 41%. Pronounced survival improvement observed among patients aged 18-39 years might mainly be explained by implementation of pediatric-based regimens since 2005, whereas among patients aged 40-69 years, increased application of RIC-alloSCT has contributed significantly to the observed improvement. Outcome of patients aged ⩾70 remains unsatisfactory, indicating a need for specific trials for the elderly.
    MeSH term(s) Adolescent ; Adult ; Aged ; Female ; Hematopoietic Stem Cell Transplantation ; Humans ; Male ; Middle Aged ; Patient Participation ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy
    Language English
    Publishing date 2016-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/leu.2015.230
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Acute anemie bij een Vietnamese patiënt met alpha-thalassemie en een Parvovirus-infectie.

    Rentenaar, R J / van Doorn, H R / Rijneveld, A W

    Nederlands tijdschrift voor geneeskunde

    2006  Volume 150, Issue 40, Page(s) 2223; author reply 2223

    Title translation Acute anaemia in a Vietnamese patient with alpha-thalassaemia and a parvovirus infection.
    MeSH term(s) Anemia/etiology ; Anemia/therapy ; Blood Transfusion ; Humans ; Parvoviridae Infections/complications ; Parvovirus B19, Human/pathogenicity ; Treatment Outcome ; alpha-Thalassemia/complications ; alpha-Thalassemia/genetics
    Language Dutch
    Publishing date 2006-10-07
    Publishing country Netherlands
    Document type Comment ; Letter
    ZDB-ID 82073-8
    ISSN 1876-8784 ; 0028-2162
    ISSN (online) 1876-8784
    ISSN 0028-2162
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Twee patiënten met lactaatacidose en hypoglykemie als uiting van een lymfoom.

    Juffermans, N P / Rijneveld, A W / Zweegman, S / Spijkstra, J J

    Nederlands tijdschrift voor geneeskunde

    2006  Volume 150, Issue 50, Page(s) 2770–2773

    Abstract: A 32-year-old man who had undergone kidney transplantation presented with malaise, severe diarrhoea, nausea and vomiting, productive cough and shortness of breath. A 42-year-old woman with no relevant medical history presented with fever, weight loss and ...

    Title translation Two patients with lactic acidosis and hypoglycaemia as initial presentation of a lymphoma.
    Abstract A 32-year-old man who had undergone kidney transplantation presented with malaise, severe diarrhoea, nausea and vomiting, productive cough and shortness of breath. A 42-year-old woman with no relevant medical history presented with fever, weight loss and abdominal pain. Both patients had lactic acidosis and hypoglycaemia. Initially, the hyperlactataemia was thought to result from tissue hypoxia (sepsis) but it persisted after correction of the hypovolaemia; therefore, alternative causes were considered. Both patients were found to have T-cell lymphoma with liver infiltration. The male patient died before treatment could be initiated. The lactic acidosis resolved in the female patient following lymphoma treatment, but she died subsequently from the lymphoma. Lymphoreticular malignancies should be considered for cases of lactic acidosis with sufficient oxygen supply, particularly when hypoglycaemia is also present. The lactic acidosis and hypoglycaemia result from increased anaerobic glycolysis in tumour cells. Tumour reduction with chemotherapy can reduce the lactic acidosis.
    MeSH term(s) Acidosis, Lactic/diagnosis ; Acidosis, Lactic/etiology ; Adult ; Fatal Outcome ; Female ; Humans ; Hypoglycemia/diagnosis ; Hypoglycemia/etiology ; Liver Neoplasms/diagnosis ; Liver Neoplasms/secondary ; Lymphoma, T-Cell/complications ; Lymphoma, T-Cell/diagnosis ; Male
    Language Dutch
    Publishing date 2006-12-16
    Publishing country Netherlands
    Document type Case Reports ; English Abstract ; Journal Article
    ZDB-ID 82073-8
    ISSN 1876-8784 ; 0028-2162
    ISSN (online) 1876-8784
    ISSN 0028-2162
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top